AMRN FY 2021 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$583M-5.0% YoY

Gross Profit

$462M79.2% margin

Operating Income

$11M1.8% margin

Net Income

$8M1.3% margin

EPS (Diluted)

$0.38

Cash Flow

Operating Cash Flow

-$67M

Free Cash Flow

-$67M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$401M

Stockholders' Equity

$667M

Cash & Equivalents

$219M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$583M	$614M	-5.0%
Gross Profit	$462M	$483M	-4.3%
Operating Income	$11M	-$20M	+153.4%
Net Income	$8M	-$18M	+142.9%